Capsule Formulation Of Pirfenidone And Pharmaceutically Acceptable Excipients

Patent No. EP1940364 (titled "Capsule Formulation Of Pirfenidone And Pharmaceutically Acceptable Excipients") was filed by Intermune on Sep 22, 2006. The application was issued on Jul 20, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DANNENBERGERMar 11, 2015DANNENBERGER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1940364

INTERMUNE
Application Number
EP06815221A
Filing Date
Sep 22, 2006
Status
Patent Maintained As Amended
Jun 17, 2022
Publication Date
Jul 20, 2022